Cidara Therapeutics Overview
Cidara Therapeutics Target Price
Analysts' 12-month price predictions for CDTX.
Get informed when a big investor buys or sells
+ FollowShare Price
$221.38
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-11-14 | RBC Capital | $221.5 |  0.1% upside |  |
| 2025-10-09 | H.C. WainwrightSara Nik | $150 |  32.2% downside | |
| 2025-10-03 | JMP Securities | $173 | 21.9% downside | |
| 2025-09-26 | H.C. Wainwright | $110 | 50.3% downside | |
| 2025-09-24 | JMP SecuritiesRoy Buchanan | $153 | 30.9% downside | |
| 2025-09-24 | GuggenheimSeamus Fernandez | $167 | 24.6% downside | |
| 2025-09-24 | RBC CapitalBrian Abrahams | $137 | 38.1% downside | |
| 2025-07-09 | GuggenheimSeamus Fernandez | $69 | 68.8% downside | |
| 2025-06-24 | Guggenheim | $68 | 69.3% downside | |
| 2025-05-16 | GuggenheimSeamus Fernandez | $50 | 77.4% downside | |
| 2025-03-12 | JMP SecuritiesRoy Buchanan | $46 | 79.2% downside | |
| 2024-08-14 | H.C. WainwrightEd Arce | $12 | 94.6% downside | |